Gestational trophoblastic disease
Information
- Disease name
- Gestational trophoblastic disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05203562 | Active, not recruiting | Phase 2/Phase 3 | Letrozole as a Prophylaxis From GTN for Complete Mole Patients | June 1, 2020 | June 1, 2023 |
| NCT00706875 | Completed | A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors | June 2008 | April 2018 | |
| NCT04047017 | Completed | Phase 2 | Camrelizumab Combined With Apatinib for Recurrent Resistant GTN | August 8, 2019 | May 15, 2021 |
| NCT06339827 | Recruiting | N/A | ASk Questions in GYnecologic Oncology (ASQ-GYO) | April 4, 2024 | May 2027 |
| NCT05635344 | Recruiting | Phase 2 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | February 14, 2024 | August 1, 2026 |
| NCT02892877 | Recruiting | The French National Reference Centre of GTD | November 1999 | November 2029 | |
| NCT03280979 | Unknown status | Phase 2/Phase 3 | Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia | October 2017 | October 2019 |
| NCT01823315 | Unknown status | Phase 3 | Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia | December 2012 | December 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D031901